Clinical Trials Directory

Trials / Completed

CompletedNCT06779019

a Prospective Study of Surgical Results, Complications and Predictive Values in Chinese Women Breast Reconstruction

Breast Enhanced Strategies and Techniques(BEST) (Focus on Chinese Breast Reconstruction) Trial PART 1: Evaluation of Predictive Methods of Reconstruction Outcomes--Flap Perfusion Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study prospectively evaluates and compares the effectiveness of ICG fluorescence imaging and LSCI in predicting the risk of necrosis following direct-to-implant breast reconstruction.

Detailed description

This study prospectively evaluates and compares the effectiveness of Indocyanine Green (ICG) fluorescence imaging and Laser Speckle Contrast Imaging (LSCI) in predicting the risk of necrosis following direct-to-implant breast reconstruction. The investigation includes both intraoperative and postoperative assessments of flap perfusion, with a focus on identifying specific thresholds for necrosis prediction. By analyzing the sensitivity, specificity, and predictive accuracy of each technique, the study aims to establish their respective strengths and limitations. Additionally, the research aims to explore the feasibility of using these methods in different surgical stages, evaluating their consistency and reliability in monitoring the viability of the skin flap and nipple-areolar complex.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLSCILSCI evaluates at 2 timings:immediately after the mastectomy (prior to immediate reconstruction) and again following reconstruction (after the skin was sutured). The perfusion score was calculated by normalizing these values against the perfusion value of a control.
DIAGNOSTIC_TESTICG (Indocyanine Green)Performed immediately after the mastectomy (prior to immediate reconstruction) .Perfusion scores were determined by comparing the fluorescence intensity of the target area to that of the non-surgical region on the contralateral chest wall.

Timeline

Start date
2022-09-01
Primary completion
2024-07-01
Completion
2024-07-01
First posted
2025-01-16
Last updated
2025-01-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06779019. Inclusion in this directory is not an endorsement.